Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines (ENFORCE PLUS)

NCT06360744 is registered in ClinicalTrials.gov with Jens D Lundgren, MD as lead sponsor.

NCT NCT06360744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06360744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines (ENFORCE PLUS)
Lead sponsor
Jens D Lundgren, MD
Phase
Phase 4
Overall status
Completed
Start date
July 5, 2021
Completion date
December 31, 2023
Enrollment
25 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sars cov 2 infection